A Randomised Controlled Trial to Compare Unfractionated Heparin Versus Bivalirudin in the Treatment of Patients With a Clinical Diagnosis of ST-Segment Elevation Myocardial Infarction Events - For Planned Management With Primary PCI.

Trial Profile

A Randomised Controlled Trial to Compare Unfractionated Heparin Versus Bivalirudin in the Treatment of Patients With a Clinical Diagnosis of ST-Segment Elevation Myocardial Infarction Events - For Planned Management With Primary PCI.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HEAT-PPCI
  • Most Recent Events

    • 30 Oct 2015 Results published early online in the Lancet
    • 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Nov 2013 Accrual to date is 98% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top